Moody’s affirms Sharp HealthCare’s “Aa3” rating

Moody’s Investors Service has affirmed the “Aa3” rating on San Diego-based Sharp HealthCare’s long-term and underlying revenue bond ratings, affecting $545 million of rated debt.

Advertisement

The rating affirmation is based on several factors, including Sharp’s improved balance sheet measures, ongoing strong operating performance and continued market share growth in San Diego County.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that Sharp will continue to maintain is strong performance measures and healthy balance sheet.

More articles on healthcare finance:
How reference pricing lowered prices for common procedures by 20% in Calif.
Survey: 1 in 3 healthcare organizations not satisfied with credentialing experience
Press Ganey sells to EQT for $2.35B

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.